CIPALIN 0.5 mg/ml Vial 10 mg Concentrate for solution for infusion 50ml Vial

Product Details

CIPALIN 0.5 mg/ml Vial is a high-quality pharmaceutical product designed for effective treatment of various bacterial infections. This sterile concentrate, provided in a 50ml vial, contains 10 mg of active Ciprofloxacin per vial, at a concentration of 0.5 mg/ml. It is intended for intravenous administration exclusively within a clinical setting, ensuring precise delivery and optimal therapeutic outcomes.

Benefits of Use

CIPALIN 0.5 mg/ml Infusion offers several significant benefits:

• Broad-spectrum antibiotic action effective against a wide range of gram-positive and gram-negative bacteria.
• Rapid onset of action when administered intravenously, crucial for severe infections.
• Targeted treatment for systemic infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections.
• Reliable formulation ensuring consistent dosage and efficacy.

How to Use

CIPALIN 0.5 mg/ml Concentrate for solution for infusion must be administered by a qualified healthcare professional.

1. Verify the integrity of the vial and inspect the solution for particulate matter or discoloration prior to administration.
2. The concentrate must be diluted according to established hospital protocols before intravenous infusion.
3. Administer the diluted solution slowly via intravenous infusion over the recommended duration, typically 30 to 60 minutes.
4. The exact dosage and duration of treatment will be determined by the physician based on the patient's condition, severity of infection, and susceptibility of the causative organism.
5. Do not administer intramuscularly, subcutaneously, or intrathecally.

Caution & Warnings

Before using CIPALIN 0.5 mg/ml Infusion, consider the following important cautions and warnings:

• Hypersensitivity: Do not use in patients with a history of hypersensitivity to ciprofloxacin or other quinolones.
• Renal Impairment: Dosage adjustment may be necessary for patients with impaired renal function; monitor kidney function closely.
• Tendonitis and Tendon Rupture: Ciprofloxacin is associated with an increased risk of tendinitis and tendon rupture, particularly in elderly patients and those receiving corticosteroids. Discontinue at the first sign of tendon pain or inflammation.
• Central Nervous System Effects: May cause dizziness, lightheadedness, confusion, and rarely seizures. Advise patients to avoid activities requiring mental alertness.
• QT Prolongation: Use with caution in patients with known prolongation of the QT interval or uncorrected hypokalemia/hypomagnesemia.
• Drug Interactions: Inform healthcare provider of all concomitant medications due to potential for significant drug interactions.
• Pregnancy & Lactation: Use only if the potential benefit justifies the potential risk to the fetus or infant.
• Photosensitivity: Advise patients to avoid excessive sun exposure and use protective measures.
• Crystalluria: Ensure adequate hydration to prevent crystalluria.

Ingredients

Each ml of CIPALIN 0.5 mg/ml Concentrate for solution for infusion contains:

• Active Ingredient: Ciprofloxacin (as lactate) 0.5 mg/ml
• Excipients: Water for injection, Lactic Acid (for pH adjustment), Sodium Chloride.